Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

BACKGROUND: Distinguishing endocervical adenocarcinoma (ECA) from endometrial mucinous adenocarcinoma (EMMA) is clinically significant in view of the differences in their management and prognosis. In this study, we used a panel of tumor markers to determine their ability to distinguish between prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoury, Thaer, Tan, Dongfeng, Wang, Jianmin, Intengan, Marilyn, Yang, Jun, Alrawi, Sadir, Yan, Peisha, Byrd, James C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382242/
https://www.ncbi.nlm.nih.gov/pubmed/16409624
http://dx.doi.org/10.1186/1472-6890-6-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382242/
https://www.ncbi.nlm.nih.gov/pubmed/16409624
http://dx.doi.org/10.1186/1472-6890-6-1

Ejemplares similares